INOVELON

This brand name is authorized in Austria, Brazil, Croatia, Cyprus, Ecuador, Estonia, Finland, France, Hong Kong SAR China, Ireland, Israel, Italy, Japan, Lithuania, Netherlands, New Zealand, Poland, Romania, Singapore, Spain, UK.

Active ingredients

The drug INOVELON contains one active pharmaceutical ingredient (API):

1	Rufinamide UNII WFW942PR79 - RUFINAMIDE
	Rufinamide is an anticonvulsant medication. Rufinamide modulates the activity of sodium channels, prolonging their inactive state.
	Read more about Rufinamide

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
INOVELON Film-coated tablet	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N03AF03	Rufinamide	N Nervous system → N03 Antiepileptics → N03A Antiepileptics → N03AF Carboxamide derivatives
Discover more medicines within N03AF03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
BR	Câmara de Regulação do Mercado de Medicamentos	533220010002417, 533220010002517, 533220010002617, 533220010002717, 542717060004202, 542717060004302, 542717060004402, 542717060004502, 542717060004602, 542717060004702, 542718070004802, 542718070004902, 542718070005002, 542718070005102
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	5748-MEE-1220, 5750-MEE-1220
EE	Ravimiamet	1280168, 1280179, 1280180, 1280191, 1280203, 1280214, 1280225, 1280236, 1280247, 1280258, 1280269, 1280270, 1280281, 1280292, 1280304, 1280315, 1549740, 1849596
ES	Centro de información online de medicamentos de la AEMPS	06378001, 06378009, 06378015, 06378017
FI	Lääkealan turvallisuus- ja kehittämiskeskus	034939, 084860, 446618, 597767
FR	Base de données publique des médicaments	62205873, 65037644, 65869160, 67454800
GB	Medicines & Healthcare Products Regulatory Agency	128622, 131240, 131243, 182687, 203439
HK	Department of Health Drug Office	64097, 64098, 64099
IE	Health Products Regulatory Authority	21546, 29701, 29730, 29785
IL	מִשְׂרַד הַבְּרִיאוּת	6669, 6670, 6671
IT	Agenzia del Farmaco	038217016, 038217028, 038217030, 038217042, 038217055, 038217067, 038217079, 038217081, 038217093, 038217105, 038217117, 038217129, 038217131, 038217143, 038217156, 038217168, 038217170
JP	医薬品医療機器総合機構	1139012F1023, 1139012F2020
LT	Valstybinė vaistų kontrolės tarnyba	1028578, 1028579, 1028580, 1028581, 1028582, 1028583, 1028584, 1028585, 1028586, 1028587, 1028588, 1028589, 1028590, 1028591, 1028592, 1064022
NL	Z-Index G-Standaard, PRK	101222, 98825, 98833
NZ	Medicines and Medical Devices Safety Authority	20996, 20997, 20998
PL	Rejestru Produktów Leczniczych	100310996, 100311004, 100311010, 100311027
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W51823001, W51823002, W51823003, W51823004, W51823005, W51824001, W51824002, W51824003, W51824004, W51824005, W51825001, W51825002, W51825003, W51825004, W51825005, W51825006
SG	Health Sciences Authority	15146P